表紙SALE
市場調查報告書
商品編碼
934758

蛋白質體學的全球市場:2025年前的各用途,各適應症,各技術,各類型、 各產品,各終端用戶,各地區的競爭,預測,機會

Global Proteomics Market, By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2026F

出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球蛋白質體學市場調查,提供各地區市場展望,市場力學,主要的趨勢,競爭情形等資訊,並提供策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 全球蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途(藥物研發,診斷生物標誌物的發現,臨床診斷,其他)
    • 各適應症(感染疾病,循環系統,神經血管,糖尿病,其他)
    • 各技術
    • 各類型(功能,表現,結構,計算)
    • 各產品(軟體,設備,試劑及化驗,服務)
    • 各終端用戶(製藥及生物科技企業、 調查機關,CRO)
    • 各公司(2019)
    • 各地區
  • 市場魅力指數

第5章 亞太地區的蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途
    • 各適應症
    • 各技術
    • 各類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國蛋白質體學市場展望
    • 印度的蛋白質體學市場展望
    • 日本的蛋白質體學市場展望
    • 韓國的蛋白質體學市場展望
    • 新加坡的蛋白質體學市場展望
    • 澳洲的蛋白質體學市場展望

第6章 歐洲的蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途
    • 各適應症
    • 各技術
    • 各類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國的蛋白質體學市場展望
    • 德國的蛋白質體學市場展望
    • 英國的蛋白質體學市場展望
    • 義大利的蛋白質體學市場展望

第7章 北美的蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途
    • 各適應症
    • 各技術
    • 各類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國蛋白質體學市場展望
    • 墨西哥的蛋白質體學市場展望
    • 加拿大的蛋白質體學市場展望

第8章 南美的蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途
    • 各適應症
    • 各技術
    • 各類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西的蛋白質體學市場展望
    • 阿根廷的蛋白質體學市場展望
    • 哥倫比亞的蛋白質體學市場展望

第9章 中東和非洲的蛋白質體學市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各用途
    • 各適應症
    • 各技術
    • 各類型
    • 各產品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東·非洲地區:國家分析
    • 南非的蛋白質體學市場展望
    • 沙烏地阿拉伯蛋白質體學市場展望
    • UAE蛋白質體學市場展望

第10章 市場動態

  • 促進因素
  • 課題

第11章 市場趨勢

第12章 競爭情形

  • 競爭的展望
  • 主要企業的簡介
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Waters Corporation
    • Bio-Rad Laboratories
    • GE Healthcare
    • PerkinElmer
    • Creative Proteomics
    • Luminex Corporation
    • Promega Corporation
    • Caprion
    • Bruker
    • Pfizer
    • Horiba
    • Qiagen
    • Becton Dickinson
    • Bioproximity
    • Biocon
    • Evotec
    • Bristol-Myers Squibb
    • Illumina
    • Takeda Pharmaceuticals

第13章 策略性建議

第14章 免責聲明

目錄
Product Code: 4559

Global proteomics market is expected to undergo a healthy growth during the forecast period and is projected to reach USD66.59 billion by 2026. The key factor responsible for increased demand for proteomics is the growing investments in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2026. However, the market is constrained by strict regulatory norms and the high cost of the instruments.

The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into clinical diagnostic, drug discovery, diagnostic biomarker discovery, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size in 2020 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem mass spectrometry and liquid chromatography are some proteomics technologies that are effective for the identification of proteins, thus boosting the growth of the segment across the globe. Based on indication, the market is segmented into oncology, infectious disease, respiratory, cardiology, others. Out of which, infectious disease segment is expected to undergo the fastest CAGR during the forecast period due to the increasing incidence of infectious diseases.

Major players operating in the global proteomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation (SCIEX), GE Healthcare, Inc., PerkinElmer, Inc., Becton, Dickinson and Company, Illumina, Inc., Biocon Limited, Qiagen N.V., Bruker Corporation, Luminex Corporation, Evotec SE, Horiba, Ltd., Creative Proteomics, Promega Corporation, CellCarta Precision Medicine, Inc., Bioproximity LLC, Applied Biomics, Inc., etc. The companies operating in proteomics market across the globe are focusing more towards expanding their share in the market. Rising competitiveness is anticipated to drive innovation in the market, therefore helping the industry to solve existing challenges and meet the unmet needs in the market. Furthermore, the market players are focusing on R&D activities to enhance their product portfolios. Also, they are adopting strategies such as collaborations and acquisitions to further bolster their status in the proteomics market. For instance, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021E
  • Forecast Period: 2022-2026F

Objective of the Study:

  • To analyze the historical growth in the market size of global proteomics market from 2016 to 2020.
  • To estimate and forecast the market size of global proteomics market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global proteomics market based on application, indication, technology, type, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global proteomics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global proteomics market.
  • To conduct pricing analysis for global proteomics market.
  • To identify and analyze the profile of leading players operating in global proteomics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Proteomics companies, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to proteomics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Proteomics Market, By Application:

  • Clinical Diagnostic
  • Drug Discovery
  • Diagnostic Biomarker Discovery
  • Others

Global Proteomics Market, By Indication:

  • Oncology
  • Infectious Disease
  • Respiratory
  • Cardiology
  • Others

Global Proteomics Market, By Technology:

  • Conventional
    • Chromatography
    • ELISA
    • Western Blotting
  • Advanced
    • Protein Microarray
    • Gel Electrophoresis
    • Mass Spectrophotometry
    • Edman Sequencing
  • Quantitative
    • Isotope-coded affinity tag (ICAT) labeling
    • Stable isotope labeling with amino acids in cell culture (SILAC)
    • Isobaric tag for relative and absolute quantitation (iTRAQ)
  • High-throughput
    • X-ray crystallography
    • NMR
  • Bioinformatic Analysis

Global Proteomics Market, By Type:

  • Expression
  • Functional
  • Structural
  • Computational

Global Proteomics Market, By Product:

  • Reagents and Assays
  • Instruments
  • Software & Services

Global Proteomics Market, By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • CROs

Global Proteomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global proteomics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Proteomics Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness & Brand Recall
  • 5.2. Factors Influencing Purchase Decision
  • 5.3. Unmet Needs & Challenges

6. Global Proteomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
    • 6.2.2. By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others)
    • 6.2.3. By Technology
      • 6.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 6.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 6.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 6.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 6.2.3.5. Bioinformatic analysis
    • 6.2.4. By Type (Expression, Functional, Structural, Computational)
    • 6.2.5. By Product (Reagents and Assays, Instruments, Software & Services)
    • 6.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
    • 6.2.7. By Company (2020)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. North America Proteomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Indication
    • 7.2.3. By Technology
      • 7.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 7.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 7.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 7.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 7.2.3.5. Bioinformatic analysis
    • 7.2.4. By Type
    • 7.2.5. By Product
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Proteomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Type
        • 7.3.1.2.5. By Product
        • 7.3.1.2.6. By End-User
    • 7.3.2. Canada Proteomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Type
        • 7.3.2.2.5. By Product
        • 7.3.2.2.6. By End-User
    • 7.3.3. Mexico Proteomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Type
        • 7.3.3.2.5. By Product
        • 7.3.3.2.6. By End-User

8. Europe Proteomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Indication
    • 8.2.3. By Technology
      • 8.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 8.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 8.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 8.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 8.2.3.5. Bioinformatic analysis
    • 8.2.4. By Type
    • 8.2.5. By Product
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Proteomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Type
        • 8.3.1.2.5. By Product
        • 8.3.1.2.6. By End-User
    • 8.3.2. United Kingdom Proteomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Type
        • 8.3.2.2.5. By Product
        • 8.3.2.2.6. By End-User
    • 8.3.3. France Proteomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Type
        • 8.3.3.2.5. By Product
        • 8.3.3.2.6. By End-User
    • 8.3.4. Italy Proteomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Type
        • 8.3.4.2.5. By Product
        • 8.3.4.2.6. By End-User
    • 8.3.5. Spain Proteomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Type
        • 8.3.5.2.5. By Product
        • 8.3.5.2.6. By End-User

9. Asia-Pacific Proteomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Indication
    • 9.2.3. By Technology
      • 9.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 9.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 9.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 9.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 9.2.3.5. Bioinformatic analysis
    • 9.2.4. By Type
    • 9.2.5. By Product
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. Japan Proteomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Type
        • 9.3.1.2.5. By Product
        • 9.3.1.2.6. By End-User
    • 9.3.2. China Proteomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Type
        • 9.3.2.2.5. By Product
        • 9.3.2.2.6. By End-User
    • 9.3.3. India Proteomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Type
        • 9.3.3.2.5. By Product
        • 9.3.3.2.6. By End-User
    • 9.3.4. South Korea Proteomics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Application
        • 9.3.4.2.2. By Indication
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Type
        • 9.3.4.2.5. By Product
        • 9.3.4.2.6. By End-User
    • 9.3.5. Australia Proteomics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Application
        • 9.3.5.2.2. By Indication
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Type
        • 9.3.5.2.5. By Product
        • 9.3.5.2.6. By End-User

10. South America Proteomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Indication
    • 10.2.3. By Technology
      • 10.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 10.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 10.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 10.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 10.2.3.5. Bioinformatic analysis
    • 10.2.4. By Type
    • 10.2.5. By Product
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Proteomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Type
        • 10.3.1.2.5. By Product
        • 10.3.1.2.6. By End-User
    • 10.3.2. Argentina Proteomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Type
        • 10.3.2.2.5. By Product
        • 10.3.2.2.6. By End-User
    • 10.3.3. Colombia Proteomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Type
        • 10.3.3.2.5. By Product
        • 10.3.3.2.6. By End-User

11. Middle East & Africa Proteomics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Application
    • 11.2.2. By Indication
    • 11.2.3. By Technology
      • 11.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
      • 11.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
      • 11.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
      • 11.2.3.4. High-throughput (X-ray crystallography, NMR)
      • 11.2.3.5. Bioinformatic analysis
    • 11.2.4. By Type
    • 11.2.5. By Product
    • 11.2.6. By End-User
    • 11.2.7. By Country
  • 11.3. Middle East & Africa: Country Analysis
    • 11.3.1. South Africa Proteomics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Application
        • 11.3.1.2.2. By Indication
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Type
        • 11.3.1.2.5. By Product
        • 11.3.1.2.6. By End-User
    • 11.3.2. Saudi Arabia Proteomics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Application
        • 11.3.2.2.2. By Indication
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Type
        • 11.3.2.2.5. By Product
        • 11.3.2.2.6. By End-User
    • 11.3.3. UAE Proteomics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Application
        • 11.3.3.2.2. By Indication
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Type
        • 11.3.3.2.5. By Product
        • 11.3.3.2.6. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Thermo Fisher Scientific, Inc.
    • 14.2.2. Agilent Technologies, Inc.
    • 14.2.3. Waters Corporation
    • 14.2.4. Bio-Rad Laboratories, Inc.
    • 14.2.5. Danaher Corporation (SCIEX)
    • 14.2.6. GE Healthcare, Inc.
    • 14.2.7. PerkinElmer, Inc.
    • 14.2.8. Becton, Dickinson and Company
    • 14.2.9. Illumina, Inc.
    • 14.2.10. Biocon Limited
    • 14.2.11. Qiagen N.V.
    • 14.2.12. Bruker Corporation
    • 14.2.13. Luminex Corporation
    • 14.2.14. Evotec SE
    • 14.2.15. Horiba, Ltd.
    • 14.2.16. Creative Proteomics
    • 14.2.17. Promega Corporation
    • 14.2.18. CellCarta Precision Medicine, Inc.
    • 14.2.19. Bioproximity LLC
    • 14.2.20. Applied Biomics, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 3: Global Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 4: Global Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 5: Global Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 6: Global Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 7: Global Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 8: Global Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 9: Global Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 10: Global Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 11: Global Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 12: Global Proteomics Market Share, By Company, 2016-2026F
  • Figure 13: Global Proteomics Market Share, By Region, 2016-2026F
  • Figure 14: Global Proteomics Market, By Product Market Map, 2016-2026F
  • Figure 15: North America Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 16: North America Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 17: North America Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 18: North America Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 19: North America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 20: North America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 21: North America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 22: North America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 23: North America Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 24: North America Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 25: North America Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 26: North America Proteomics Market Share, By Country, By Value, 2016-2026F
  • Figure 27: United States Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 28: United States Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 29: United States Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 30: United States Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 31: United States Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 32: United States Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 33: United States Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 34: Canada Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 35: Canada Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 36: Canada Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 37: Canada Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 38: Canada Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 39: Canada Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 40: Canada Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 41: Mexico Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 42: Mexico Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 43: Mexico Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 44: Mexico Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 45: Mexico Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 46: Mexico Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 47: Mexico Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 48: Europe Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: Europe Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 50: Europe Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 51: Europe Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 52: Europe Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 53: Europe Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 54: Europe Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 55: Europe Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 56: Europe Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 57: Europe Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 58: Europe Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 59: Europe Proteomics Market Share, By Country, By Value, 2016-2026F
  • Figure 60: Germany Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 61: Germany Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 62: Germany Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 63: Germany Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 64: Germany Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 65: Germany Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 66: Germany Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 67: United Kingdom Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 68: United Kingdom Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 69: United Kingdom Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 70: United Kingdom Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 71: United Kingdom Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 72: United Kingdom Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 73: United Kingdom Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 74: France Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 75: France Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 76: France Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 77: France Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 78: France Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 79: France Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 80: France Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 81: Italy Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 82: Italy Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 83: Italy Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 84: Italy Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 85: Italy Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 86: Italy Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 87: Italy Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 88: Spain Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 89: Spain Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 90: Spain Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 91: Spain Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 92: Spain Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 93: Spain Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 94: Spain Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 95: Asia-Pacific Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 96: Asia-Pacific Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 97: Asia-Pacific Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 98: Asia-Pacific Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 99: Asia-Pacific Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 100: Asia-Pacific Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 101: Asia-Pacific Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 102: Asia-Pacific Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 103: Asia-Pacific Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 104: Asia-Pacific Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 105: Asia-Pacific Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 106: Asia-Pacific Proteomics Market Share, By Country, By Value, 2016-2026F
  • Figure 107: Japan Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 108: Japan Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 109: Japan Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 110: Japan Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 111: Japan Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 112: Japan Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 113: Japan Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 114: China Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 115: China Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 116: China Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 117: China Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 118: China Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 119: China Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 120: China Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 121: India Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 122: India Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 123: India Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 124: India Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 125: India Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 126: India Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 127: India Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 128: South Korea Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 129: South Korea Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 130: South Korea Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 131: South Korea Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 132: South Korea Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 133: South Korea Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 134: South Korea Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 135: Australia Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 136: Australia Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 137: Australia Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 138: Australia Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 139: Australia Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 140: Australia Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 141: Australia Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 142: South America Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 143: South America Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 144: South America Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 145: South America Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 146: South America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 147: South America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 148: South America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 149: South America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 150: South America Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 151: South America Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 152: South America Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 153: South America Proteomics Market Share, By Country, By Value, 2016-2026F
  • Figure 154: Brazil Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 155: Brazil Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 156: Brazil Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 157: Brazil Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 158: Brazil Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 159: Brazil Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 160: Brazil Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 161: Argentina Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 162: Argentina Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 163: Argentina Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 164: Argentina Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 165: Argentina Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 166: Argentina Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 167: Argentina Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 168: Colombia Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 169: Colombia Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 170: Colombia Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 171: Colombia Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 172: Colombia Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 173: Colombia Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 174: Colombia Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 175: Middle East & Africa Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 176: Middle East & Africa Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 177: Middle East & Africa Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 178: Middle East & Africa Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 179: Middle East & Africa Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
  • Figure 180: Middle East & Africa Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
  • Figure 181: Middle East & Africa Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
  • Figure 182: Middle East & Africa Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
  • Figure 183: Middle East & Africa Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 184: Middle East & Africa Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 185: Middle East & Africa Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 186: Middle East & Africa Proteomics Market, By Country, By Value, 2016-2026F
  • Figure 187: South Africa Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 188: South Africa Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 189: South Africa Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 190: South Africa Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 191: South Africa Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 192: South Africa Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 193: South Africa Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 194: Saudi Arabia Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 195: Saudi Arabia Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 196: Saudi Arabia Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 197: Saudi Arabia Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 198: Saudi Arabia Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 199: Saudi Arabia Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 200: Saudi Arabia Proteomics Market Share, By End User, By Value, 2016-2026F
  • Figure 201: UAE Proteomics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 202: UAE Proteomics Market Share, By Application, By Value, 2016-2026F
  • Figure 203: UAE Proteomics Market Share, By Indication, By Value, 2016-2026F
  • Figure 204: UAE Proteomics Market Share, By Technology, By Value, 2016-2026F
  • Figure 205: UAE Proteomics Market Share, By Type, By Value, 2016-2026F
  • Figure 206: UAE Proteomics Market Share, By Product, By Value, 2016-2026F
  • Figure 207: UAE Proteomics Market Share, By End User, By Value, 2016-2026F